Fusion Pharmaceuticals Inc. DFFN · Stock Open Fusion Pharmaceuticals Inc. in new tab
Fusion Pharmaceuticals Inc. Analysis (DFFN)
Is Fusion Pharmaceuticals Inc. a good investment? Fusion Pharmaceuticals Inc. (DFFN) is currently trading at 4.40 USD.
Investor FAQ
Does Fusion Pharmaceuticals Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Fusion Pharmaceuticals Inc.?
Fusion Pharmaceuticals Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
Company Profile
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.
| Split Date | Split Ratio to 1 |
|---|---|
| March 10, 2014 | 1:100 |
| Aug. 19, 2016 | 1:10 |
| April 19, 2022 | 1:50 |
| Aug. 17, 2023 | 0.67 |
Community Discussion